Physician profile
Cody Ramirez
NPI 1922503655
$33,716.73
in general payments reported to CMS, 2019-2025
8 companies · $6,188 in 2025
The $6,188 reported for 2025 was more than what 83% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $23K · 2024: $4,782 · 2025: $6,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $23K · Travel and Lodging: $5,593 · Food and Beverage: $3,123 · Education: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $22,500.00 |
| Travel and Lodging | $5,593.41 |
| Food and Beverage | $3,123.32 |
| Education | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2023 | |
| Smith+Nephew, INC. | $10,294.60 | 2023-2025 | Healicoil, Q-Fix, Acufex Meniscal Root Repair |
| Stryker Corporation | $3,320.24 | 2023-2025 | Blueprint Patient Specific Instrumentation, Salvation, Inspace |
| Ge Healthcare | $27.22 | 2025 | |
| Vericel Corporation | $21.56 | 2025 | Maci |
| Depuy Synthes Sales INC. | $18.83 | 2025 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $17.97 | 2025 | |
| Medacta USA, INC. | $16.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.